Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Related Articles by Review for PubMed (Select 18400976)

1.

Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy.

Wilson CC, Newman MJ, Livingston BD, MaWhinney S, Forster JE, Scott J, Schooley RT, Benson CA.

Clin Vaccine Immunol. 2008 Jun;15(6):986-94. doi: 10.1128/CVI.00492-07. Epub 2008 Apr 9.

2.

Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.

Ferrari G, Kostyu DD, Cox J, Dawson DV, Flores J, Weinhold KJ, Osmanov S.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. Review.

PMID:
11018863
3.

Progress in the development of an HIV-1 vaccine.

Letvin NL.

Science. 1998 Jun 19;280(5371):1875-80. Review.

PMID:
9632379
4.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
5.

Vaccines and vaccine strategies against HIV.

Stratov I, DeRose R, Purcell DF, Kent SJ.

Curr Drug Targets. 2004 Jan;5(1):71-88. Review.

PMID:
14738219
6.

Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate.

Bellino S, Francavilla V, Longo O, Tripiciano A, Paniccia G, Arancio A, Fiorelli V, Scoglio A, Collacchi B, Campagna M, Lazzarin A, Tambussi G, Din CT, Visintini R, Narciso P, Antinori A, D'Offizi G, Giulianelli M, Carta M, Di Carlo A, Palamara G, Giuliani M, Laguardia ME, Monini P, Magnani M, Ensoli F, Ensoli B.

Rev Recent Clin Trials. 2009 Sep;4(3):195-204. Review.

PMID:
20028332
7.

HIV-1 DNA vaccines.

Fomsgaard A.

Immunol Lett. 1999 Jan;65(1-2):127-31. Review.

PMID:
10065638
8.

Nanochemistry-based immunotherapy for HIV-1.

Lori F, Calarota SA, Lisziewicz J.

Curr Med Chem. 2007;14(18):1911-9. Review.

PMID:
17691933
9.

Cellular HIV-1 immune responses in natural infection and after genetic immunization.

Calarota SA, Wahren B.

Scand J Infect Dis. 2001;33(2):83-96. Review.

PMID:
11233857
10.

Immunization. Update: search for an AIDS vaccine.

Bende S, Johnston MI.

AIDS Read. 2000 Sep;10(9):526-32, 534-8. Review.

PMID:
11019448
11.

T-lymphocyte epitope identification and their use in vaccine development for HIV-1.

Newman MJ, Livingston B, McKinney DM, Chesnut RW, Sette A.

Front Biosci. 2002 Jun 1;7:d1503-15. Review.

PMID:
12048179
12.

Therapeutic immunization for HIV.

Gudmundsdotter L, Sjödin A, Boström AC, Hejdeman B, Theve-Palm R, Alaeus A, Lidman K, Wahren B.

Springer Semin Immunopathol. 2006 Nov;28(3):221-30. Epub 2006 Oct 10. Review.

PMID:
17031650
13.

DNA vaccines against human immunodeficiency virus type 1.

Estcourt MJ, McMichael AJ, Hanke T.

Immunol Rev. 2004 Jun;199:144-55. Review.

PMID:
15233732
14.

Immunological approaches for HIV therapy.

Lori F, Kelly LM, Lisziewicz J.

Curr Drug Targets Infect Disord. 2003 Jun;3(2):171-8. Review.

PMID:
12769793
15.
16.

DNA mucosal HIV vaccine in humans.

Lundholm P, Leandersson AC, Christensson B, Bratt G, Sandström E, Wahren B.

Virus Res. 2002 Jan 30;82(1-2):141-5. Review.

PMID:
11885941
17.

Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens.

Sommerfelt MA, Sørensen B.

Expert Opin Biol Ther. 2008 Jun;8(6):745-57. doi: 10.1517/14712598.8.6.745 . Review.

PMID:
18476786
18.
19.

[Status and current strategies of HIV vaccine development].

Wild J, Wagner R.

Internist (Berl). 2003 Jun;44(6):711-8. Review. German.

PMID:
14567107
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk